Postępy w Kardiologii Interwencyjnej

Association of total Q/R ratio with myocardial scar in patients with chronic total occlusion

Busra Guvendi Sengor 1
,
Mustafa Ferhat Keten 1
,
Cemalettin Yılmaz 2
,
Kahyaoğlu Muzaffer 1
,
Suleyman C. Efe 1
,
Mustafa Kara 1
,
Tuba Unkun 1
,
Aykun Hakgör 3
,
Elnur Alizade 1
,
Regayip Zehir 1

  1. Kartal Kosuyolu Research and Education Hospital, Department of Cardiology, Turkey

  2. School of Medicine, Yalova University, Department of Cardiology, Turkey

  3. Medipol Mega University Hospital, Department of Cardiology, Turkey

Adv Interv Cardiol

DOI: https://doi.org/10.5114/aic.2026.162181
Data publikacji online: 2026/06/01
Article file
Association of total.pdf
  1. Fefer P, Knudtson ML, Cheema AN, et al. Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry. J Am Coll Cardiol 2012; 59: 991-7.
  2. Hoebers LP, Claessen BE, Dangas GD, et al. Contemporary overview and clinical perspectives of chronic total occlusions. Nat Rev Cardiol 2014; 11: 458-69.
  3. Ladwiniec A, Allgar V, Thackray S, et al. Medical therapy, percutaneous coronary intervention and prognosis in patients with chronic total occlusions. Heart 2015; 101: 1907-14.
  4. Joyal D, Afilalo J, Rinfret S. Effectiveness of recanalization of chronic total occlusions: a systematic review and meta-analysis. Am Heart J 2010; 160: 179-87.
  5. Galassi AR, Vadalà G, Werner GS, et al. Evaluation and management of patients with coronary chronic total occlusions considered for revascularization. A clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC, the European Association of Cardiovascular Imaging (EACVI) of the ESC, and the ESC Working Group on Cardiovascular Surgery. EuroIntervention 2024; 20: e174-84.
  6. Löffler AI, Kramer CM. Myocardial viability testing to guide coronary revascularization. Interv Cardiol Clin 2018; 7: 355-65.
  7. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008; 117: 1283-91. 
  8. Markendorf S, Benz DC, Messerli M, et al. Value of 12-lead electrocardiogram to predict myocardial scar on FDG PET in heart failure patients. J Nucl Cardiol 2021; 28: 1364-73.
  9. Yang H, Pu M, Rodriguez D, et al. Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography. J Am Coll Cardiol 2004; 43: 592-8.
  10. Sinno MC, Kowalski M, Kenigsberg DN, et al. R-wave amplitude changes measured by electrocardiography during early transmural ischemia. J Electrocardiol 2008; 41: 425-30.
  11. Schneider CA, Voth E, Baer FM, et al. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction. Circulation 1997; 96: 3913-20.
  12. Mobilia G, Zanco P, Desideri A, et al. T wave normalization in infarct-related electrocardiographic leads during exercise testing for detection of residual viability: comparison with positron emission tomography. J Am Coll Cardiol 1998; 32: 75-82.
  13. Badertscher P, Strebel I, Honegger U, et al. Automatically computed ECG algorithm for the quantification of myocardial scar and the prediction of mortality. Clin Res Cardiol 2018; 107: 824-35.
  14. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020; 41: 111-88.
  15. Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1-39.e14.
  16. Klocke FJ, Baird MG, Lorell BH, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiol 2003; 42: 1318-33.
  17. Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med Mol Imaging 2004; 31: 261-91.
  18. Fathala A. Myocardial perfusion scintigraphy: techniques, interpretation, indications and reporting. Ann Saudi Med 2011; 31: 625-34.
  19. Ybarra LF, Rinfret S, Brilakis ES, et al. Definitions and clinical trial design principles for coronary artery chronic total occlusion therapies: CTO-ARC consensus recommendations. Circulation 2021; 143: 479-500.
  20. Rentrop KP, Cohen M, Blanke H, et al. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-92.
  21. Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes: the J-CTO (Multicenter CTO Registry in Japan) score as a difficulty grading and time assessment tool. JACC Cardiovasc Interv 2011; 4: 213-21.
  22. Polcwiartek C, Kragholm K, Friedman DJ, et al. Long-term prognostic value of less-stringent electrocardiographic Q waves and fourth universal definition of myocardial infarction Q waves. Am J Med 2020; 133: 582-9.e7.
  23. Hamzaraj K, Kammerlander A, Gyöngyösi M, et al. Patient selection and clinical indication for chronic total occlusion revascularization-a workflow focusing on non-invasive cardiac imaging. Life (Basel) 2022; 13: 4.
  24. Al-Mohammad A, Norton MY, Mahy IR, et al. Can the surface electrocardiogram be used to predict myocardial viability? Heart 1999; 82: 663-7.
  25. Kumpamool P, Chokesuwattanaskul R, Petchlorlian A, et al. Prediction of nonviable myocardium by ECG Q-Wave parameters: a 3.0 T cardiovascular magnetic resonance study. Indian Heart J 2022; 74: 105-9.
  26. Hayıroğlu Mİ, Uzun AO, Keskin M, et al. A simple independent prognostic electrocardiography parameter in first acute anterior myocardial infarction; precordial total Q wave/precordial total R wave. J Electrocardiol 2018; 51: 38-45.
  27. Sadeghi R, Dabbagh VR, Tayyebi M, et al. Diagnostic value of fragmented QRS complex in myocardial scar detection: systematic review and meta-analysis of the literature. Kardiol Pol 2016; 74: 331-7.
  28. Inoue YY, Ambale-Venkatesh B, Mewton N, et al. Electrocardiographic impact of myocardial diffuse fibrosis and scar: MESA (Multi-Ethnic Study of Atherosclerosis). Radiology 2017; 282: 690-8.
  29. Yang X, Tian J, Zhang L, et al. Myocardial viability, functional status, and collaterals of patients with chronically occluded coronary arteries. Front Cardiovasc Med 2021; 8: 754826.
Copyright: © 2026 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees
Indexed in
pubmed
Integrated with
integrated with publons
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications